HUMIRA (adalimumab) Injection is used to treat Rheumatoid Arthritis (RA), Psoriatic Arthritis, Ankylosing Spondylitis, Crohn’s Disease, Plaque Psoriasis.

HUMIRA is a tumor necrosis factor (TNF) blocker indicated for treatment of Rheumatoid Arthritis (RA), Psoriatic Arthritis, Ankylosing Spondylitis, Crohn’s Disease, Plaque Psoriasis.

Adalimumab, sold under the brand name Humira among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis. Use is generally only recommended in people who have not responded to other treatments. Adalimumab was approved for medical use in the United States in 2002. It is on the World Health Organization's List of Essential Medicines, which lists the safest and most effective medicines needed in a health system.

Trade Name: Humira (adalimumab)

Generic Name: adalimumab

• 40 mg/0.8 mL in a single-use prefilled pen (HUMIRA Pen)
• 40 mg/0.8 mL in a single-use prefilled glass syringe

HUMIRA (adalimumab) Injection suppliers in India

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of HUMIRA (adalimumab) Injection brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 / 9891296838 or Email Us to know more details about the medicine and its cost price in India.

The order for HUMIRA (adalimumab) Injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Humira (adalimumab)

GET IN TOUCH
with Indian Pharma Network

Indian Pharma Network, Delhi provides access to Humira (adalimumab) on the Named Patient Import basis in India.

Facilitator under Named Patient Supply.

Head Office of Indian Pharma Network (IPN) is in New Delhi, INDIA. Indian Pharma Network (IPN) act as a facilitator for you, under Named Patient Supply for anti-cancer medicines.

For overseas patient " HUMIRA (adalimumab) Injection " brands can be also made available to overseas patients, doctors and hospitals at China, Cambodia, Indonesia, Nepal, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

News / Update for HUMIRA (adalimumab).

For HUMIRA (adalimumab) Injection Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

UCB's dual inhibitor outshines AbbVie's Humira in phase 3 psoriasis test For More Details

Pfizer Wins FDA Approval for Biosimilar of AbbVie’s Humira For More Details

IPN, New Delhi a trusted pharmaceutical exporter and wholesaler for Anti-Cancer Medicines in India.
Branch Office in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jodhpur